This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2030 Remove Communication Remove Process Improvement Related Topics
Health Compliance Packaging Documentation Dosage Compounding Labelling Vaccines FDA Health and Personal Care Stores Hospitals More Related Topics >
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

SEPTEMBER 11, 2023

Nature Communications 12, no. Worldwide Modular Facilities in Pharmaceutical and Biotechnology Industry to 2030 - Impact Analysis of COVID-19.” www.prnewswire.com/news-releases/worldwide-modular-facilities-in-pharmaceutical-and-biotechnology-industry-to-2030 impact-analysis-of-covid-19-301332565.html 3 (2020):e2970.

Health and Personal Care Stores 52
Health and Personal Care Stores Vaccines Packaging Documentation 52
article thumbnail

Environmental Sustainability in Biopharmaceutical Facility Design

ISPE

MARCH 15, 2023

linear) design process is central to successfully attaining such comprehensive sustainability goals and project needs (see Figure 1). Transforming Our World: The 2030 Agenda for Sustainable Development.” You may unsubscribe from these ISPE communications at any time. 7 An integrative (vs. 1 Circular Economy Practitioner Guide.

Packaging 52
Packaging Labelling Health Compliance Process Improvement 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024